Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Gastrointestinal Stromal Tumors 31Colorectal Neoplasms 12Pancreatic Neoplasms 11Carcinoma, Hepatocellular 11Stomach Neoplasms 8Neoplasms 7Liver Neoplasms 7Esophageal Neoplasms 6Carcinoma, Renal Cell 6Neoplasm Metastasis 5Gastrointestinal Neoplasms 5Adenoma, Islet Cell 5Neuroendocrine Tumors 4Carcinoma, Non-Small-Cell Lung 4Breast Neoplasms 4Prostatic Neoplasms 3Carcinoma 3Thyroid Neoplasms 2Sarcoma 2Rectal Neoplasms 2Neoplasms, Glandular and Epithelial 2Neoplasms by Site 2Neoplasms by Histologic Type 2Multiple Myeloma 2Lung Neoplasms 2Hematologic Neoplasms 2Digestive System Neoplasms 2Colonic Neoplasms 2Adenoma 2Adenocarcinoma Of Esophagus 2

Interventions

Trastuzumab 2Oxaliplatin 2Melphalan 2Leucovorin 2tipifarnib 1napabucasin 1irinotecan sucrosofate 1folfirinox 1Temozolomide 1Taxes 1Sunitinib 1Paclitaxel 1Irinotecan 1Interleukin-12 Subunit p35 1Interleukin-12 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1Fluorouracil 1Floxuridine 1Filgrastim 1Fentanyl 1Everolimus 1Cytokines 1Capecitabine 1Bevacizumab 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Islet Cell × Sunitinib × Gastrointestinal × Clear all
NCT00428597 2010-10-11

A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors

Pfizer

Phase 3 Terminated
171 enrolled 28 charts
Gastrointestinal

Pancreatic Neoplasms, Carcinoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡